Arthur Higgins

Arthur Joseph Higgins was the founder of Ascendancy Healthcare, Inc., founded in 2011, where the title held was Executive Chairman.
Current jobs include Deputy Chairman at UNION Therapeutics A since 2021, Independent Director at Zimmer Biomet Holdings, Inc. since 2012, and Director at Moksha8 Pharmaceuticals, Inc. Former jobs include President, Chief Executive Officer & Director at Assertio Therapeutics, Inc. from 2017 to 2020; Chairman & Chief Executive Officer at Bayer Healthcare LLC in 2011; Chairman at Bayer Schering Pharma AG in 2007; Chairman-Management Board at Bayer HealthCare AG from 2006 to 2010; Chairman at Bayer Pharma AG; Chairman-Biotechnology Council at National Pharmaceutical Council; Chairman at BioNJ, Inc.; Non-Executive Chairman at Assertio Holdings, Inc. in 2020; Director at Enzon Pharmaceuticals, Inc. in 2004; Director at Endo Health Solutions, Inc. from 2013 to 2014; Independent Director at Resverlogix Corp.
from 2012 to 2014; Independent Director at Endo International Plc from 2014 to 2017; Director at Pharmaceutical Research & Manufacturers of America; Director at Catalent Pharma Solutions, Inc.; Director at Zimmer US, Inc.; Independent Director at Ecolab, Inc. from 2010 to 2025; Director at Nuvelution Pharma, Inc.; President-Pharmaceutical Products Division at Abbott Laboratories from 1998 to 2001; Vice President at Bristol Myers Squibb Co.; Principal at Sandoz, Inc. in 1984; Council Member at International Federation of Pharmaceutical Manufacturers; Member at Blackstone Healthcare Partners LLC from 2010 to 2021; President at European Federation of Pharmaceutical Industries & Assns from 2007 to 2009; Principal at Fisons Ltd. in 1987.
Education includes an undergraduate degree from the University of Strathclyde, conferred in 1978.